Search Results for: CTNNB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SSTR3 somatostatin receptor 3
  • Peptide ligand-binding receptors
  • G alpha (i) signalling events
  • BBSome-mediated cargo-targeting to cilium
  • Pasireotide
  • Somatostatin
  • Lutetium Lu 177 dotatate
  • Edotreotide gallium Ga-68
STUB1 STIP1 homology and U-box containing protein 1
  • Downregulation of TGF-beta receptor signaling
  • RIPK1-mediated regulated necrosis
  • Regulation of TNFR1 signaling
  • Regulation of necroptotic cell death
  • Downregulation of ERBB2 signaling
  • Regulation of RUNX2 expression and activity
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
SYNE2 spectrin repeat containing nuclear envelope protein 2
  • Meiotic synapsis
  • Emery-Dreifuss muscular dystrophy
TAX1BP3 Tax1 binding protein 3
  • RHO GTPases Activate Rhotekin and Rhophilins
TBL1X transducin beta like 1 X-linked
  • BMAL1:CLOCK,NPAS2 activates circadian expression
  • PPARA activates gene expression
  • PPARA activates gene expression
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of gene expression by SREBF (SREBP)
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HDACs deacetylate histones
  • Notch-HLH transcription pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by PPARalpha
  • Loss of MECP2 binding ability to the NCoR/SMRT complex
  • Regulation of MECP2 expression and activity
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • HCMV Early Events
  • Cytoprotection by HMOX1
  • Heme signaling
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Expression of BMAL (ARNTL), CLOCK, and NPAS2
  • RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
TCF3 transcription factor 3
  • Myogenesis
  • Myogenesis
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Negative Regulation of CDH1 Gene Transcription
  • TGFBR3 expression
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
TCF4 transcription factor 4
  • Myogenesis
  • Myogenesis
  • TGFBR3 expression
  • Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome
TCF7L1 transcription factor 7 like 1
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex
  • Ca2+ pathway
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • Repression of WNT target genes
  • Repression of WNT target genes
  • RUNX3 regulates WNT signaling
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • Specification of the neural plate border
  • Regulation of PD-L1(CD274) transcription
TCF7L2 transcription factor 7 like 2
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex
  • Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
  • Ca2+ pathway
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • Repression of WNT target genes
  • Repression of WNT target genes
  • Signaling by TCF7L2 mutants
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates WNT signaling
  • Formation of definitive endoderm
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • Regulation of PD-L1(CD274) transcription
  • Type II diabetes mellitus
TFAP2A transcription factor AP-2 alpha
  • Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • TFAP2 (AP-2) family regulates transcription of other transcription factors
  • Activation of the TFAP2 (AP-2) family of transcription factors
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
  • Positive Regulation of CDH1 Gene Transcription
  • Regulation of MITF-M-dependent genes involved in pigmentation
  • Specification of the neural plate border
  • Specification of the neural plate border
  • Developmental Lineage of Mammary Stem Cells
  • Branchiooculofacial syndrome (BOFS)
TGFBR1 transforming growth factor beta receptor 1
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • UCH proteinases
  • Ub-specific processing proteases
  • TGFBR3 regulates TGF-beta signaling
  • 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
  • Naphthyridine Inhibitor
  • 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole
  • N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide
  • 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
  • N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
  • Fostamatinib
  • Loeys-Dietz syndrome (LDS)
  • Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
TGFBR2 transforming growth factor beta receptor 2
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • UCH proteinases
  • TGFBR3 regulates TGF-beta signaling
  • Foreskin fibroblast (neonatal)
  • Foreskin keratinocyte (neonatal)
  • Fostamatinib
  • Loeys-Dietz syndrome (LDS)
  • Colorectal cancer
  • Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
TJP1 tight junction protein 1
  • Regulation of gap junction activity
  • Regulation of gap junction activity
  • Signaling by Hippo
  • Apoptotic cleavage of cell adhesion proteins
  • RUNX1 regulates expression of components of tight junctions
  • SARS-CoV-2 targets PDZ proteins in cell-cell junction
  • SARS-CoV-2 targets PDZ proteins in cell-cell junction
TLE1 TLE family member 1, transcriptional corepressor
  • Formation of the beta-catenin:TCF transactivating complex
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Deactivation of the beta-catenin transactivating complex
  • Repression of WNT target genes
  • Repression of WNT target genes
  • Negative Regulation of CDH1 Gene Transcription
TRIM26 tripartite motif containing 26
  • Interferon gamma signaling
TRIM33 tripartite motif containing 33
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Germ layer formation at gastrulation
TRIM55 tripartite motif containing 55
TRIM63 tripartite motif containing 63
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Antigen processing: Ubiquitination & Proteasome degradation
TRIP10 thyroid hormone receptor interactor 10
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
TRRAP transformation/transcription domain associated protein
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • HATs acetylate histones
  • Ub-specific processing proteases

Page 21 out of 22 pages